WFDC2 concentrations were significantly higher in patients with gastric, lung, colorectal, esophageal, and pancreatic cancers compared to healthy donors (p < 0.01 for all comparisons, Steel test) (Figure 3C). Here, WFDC2 is linked to pancreatic neoplasm.